PhotonPharma Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$500K
- Investors
-
2
PhotonPharma General Information
Description
Developer of cancer immunotherapy designed to present tumor antigens to the patient, triggering a multi-antigen immune response. The company's immunotherapy technology uses a novel process that inactivates tumor cells while leaving them alive, that is combined with an adjuvant, enabling patients to either treat existing cancer or prevent metastasis.
Contact Information
Website
www.photonpharmaceuticals.comCorporate Office
- Research Innovation Center, 3185 Rampart Road
- D 230
- Fort Collins, CO 80521
- United States
Corporate Office
- Research Innovation Center, 3185 Rampart Road
- D 230
- Fort Collins, CO 80521
- United States
PhotonPharma Timeline
PhotonPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 01-Sep-2026 | $500K | Completed | Clinical Trials - Phase 1 | ||
| 4. Seed Round | 21-Aug-2024 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 03-Apr-2024 | Completed | Startup | |||
| 2. Accelerator/Incubator | 16-Nov-2023 | $248K | $3.16M | Completed | Stealth | |
| 1. Seed Round | 29-Aug-2023 | $2.91M | $2.91M | Completed | Stealth |
PhotonPharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PhotonPharma Comparisons
Industry
Financing
Details
PhotonPharma Competitors (3)
One of PhotonPharma’s 3 competitors is Cybrexa Therapeutics, a Venture Capital-Backed company based in New Haven, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cybrexa Therapeutics | Venture Capital-Backed | New Haven, CT | ||||
| Jubilant Therapeutics | Corporation | Allentown, PA | ||||
| Lantern Pharma | Formerly VC-backed | Dallas, TX |
PhotonPharma Patents
PhotonPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026213360-A1 | Cancer vaccine combination treatments | Pending | 01-Apr-2025 | ||
| WO-2026180950-A1 | Systems, devices, and methods for cell-based therapies | Pending | 25-Feb-2025 |
PhotonPharma Signals
PhotonPharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Colorado Venture Capital Authority | Government | |||
| CSU Starta | Corporation | Minority |
PhotonPharma FAQs
-
When was PhotonPharma founded?
PhotonPharma was founded in 2018.
-
Where is PhotonPharma headquartered?
PhotonPharma is headquartered in Fort Collins, CO.
-
What is the size of PhotonPharma?
PhotonPharma has 8 total employees.
-
What industry is PhotonPharma in?
PhotonPharma’s primary industry is Drug Discovery.
-
Is PhotonPharma a private or public company?
PhotonPharma is a Private company.
-
What is PhotonPharma’s current revenue?
The current revenue for PhotonPharma is .
-
How much funding has PhotonPharma raised over time?
PhotonPharma has raised $6.66M.
-
Who are PhotonPharma’s investors?
Colorado Venture Capital Authority and CSU Starta have invested in PhotonPharma.
-
Who are PhotonPharma’s competitors?
Cybrexa Therapeutics, Jubilant Therapeutics, and Lantern Pharma are competitors of PhotonPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process